About Cencora, Inc. Common Stock
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.
2BBBullish & Bearish
Cencora, Inc. Common Stock (COR) trades on NYSE. It operates in the Health Care sector, Medical Distribution industry. Its current 2BB score is 37 out of 100.
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.
Cencora, Inc. Common Stock’s current 2BB score is 37 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 29 | Low |
| Momentum | 69 | Improving |
| Financial strength | 51 | Normal |
| Company Presence | 64 | Strong |
| Risk | 25 | Low (provisional) |
| CEO | Robert Mauch |
| Founded | 1871 |
| Employees | 49K |
| 52-week range | $244.82 – $377.54 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-05-04 | — | 5.2284 | — | $82.58B |
| 2027-02-02 | — | 4.6219 | — | $90.90B |
| 2026-11-04 | — | 4.6213 | — | $88.88B |
| 2026-08-05 | — | 4.3924 | — | $85.16B |